Prosecution Insights
Prosecution Insights
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (14%) |
| §103 only | 5 (71%) |
| No statute on record | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BULLINGTON, ROBERT P | 1 | 43.2% | +30.3% |
| DONOHUE, SEAN R | 1 | 41.5% | +21.7% |
| CANDELARIA, JULIANA IRENE | 1 | — | — |
| DICKINSON, PAUL W | 1 | 63.0% | +9.5% |
| JADHAO, SAMADHAN JAISING | 1 | 50.0% | +45.2% |
| ANGELL, JON E | 1 | 70.7% | +21.1% |
| WOITACH, JOSEPH T | 1 | 49.1% | +27.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18551277 | Systems and Methods for Predicting Behavioral Traits | BULLINGTON, ROBERT P | 1d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17441588 | VIRUS-LIKE PARTICLES AND USES THEREOF | JADHAO, SAMADHAN JAISING | 44d overdue |
| 17315987 | METHODS FOR GENERATING MACROPHAGES WITH ENHANCED CANCER PHAGOCYTOSIS | ANGELL, JON E | 17d overdue |
| 17287448 | CANCER SPECIFIC IMMUNOTHERAPEUTIC TARGETS GENERATED BY CHEMOTHERAPEUTIC DRUG TREATMENT | WOITACH, JOSEPH T | 8d overdue |
| 18123236 | Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy | DONOHUE, SEAN R | 2d overdue |
| 18551277 | Systems and Methods for Predicting Behavioral Traits | BULLINGTON, ROBERT P | 1d overdue |
| Art Unit | Apps |
|---|---|
| 1618 | 2 |
| 3715 | 1 |
| 1634 | 1 |
| 1672 | 1 |
| 1637 | 1 |
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18551277 | Systems and Methods for Predicting Behavioral Traits | BULLINGTON, ROBERT P | 3715 | §101 | Final Rejection | 1d overdue | Pending | Sep 19, 2023 |
| 18123236 | Small Molecule Ligand-Drug Conjugates for Targeted Cancer Therapy | DONOHUE, SEAN R | 1618 | §103 | Final Rejection | 2d overdue | Pending | Mar 17, 2023 |
| 17996573 | SIRPa Deficient Macrophages for Treating Cancer | CANDELARIA, JULIANA IRENE | 1634 | Other | Non-Final OA | 32d overdue | Pending | Oct 19, 2022 |
| 17610892 | SENSORS AND METHODS USING ELECTROCHEMILUMINESCENCE OF METAL NANOCLUSTERS | DICKINSON, PAUL W | 1618 | §103 | Non-Final OA | 12d | Pending | Nov 12, 2021 |
| 17441588 | VIRUS-LIKE PARTICLES AND USES THEREOF | JADHAO, SAMADHAN JAISING | 1672 | §103 | Final Rejection | 44d overdue | Pending | Sep 21, 2021 |
| 17315987 | METHODS FOR GENERATING MACROPHAGES WITH ENHANCED CANCER PHAGOCYTOSIS | ANGELL, JON E | 1637 | §103 | Non-Final OA | 17d overdue | Pending | May 10, 2021 |
| 17287448 | CANCER SPECIFIC IMMUNOTHERAPEUTIC TARGETS GENERATED BY CHEMOTHERAPEUTIC DRUG TREATMENT | WOITACH, JOSEPH T | 1687 | §103 | Final Rejection | 8d overdue | Pending | Apr 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial